Perceptive Advisors LLC Revance Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.65 - $9.31 $2.79 Million - $5.59 Million	600,000 New	600,000 $2.95 Million
Q4 2022 Feb 14, 2023	SELL	$18.32 - $30.66 $1.46 Million - $2.44 Million	-79,574 Reduced 9.84%	729,097 $13.5 Million
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $3.38 Million - $6.72 Million	236,157 Added 41.25%	808,671 $21.8 Million
Q2 2022 Aug 15, 2022	BUY	$11.52 - $20.4 $5.01 Million - $8.87 Million	435,000 Added 316.33%	572,514 $7.91 Million
Q1 2022 May 16, 2022	BUY	$12.36 - $20.31 $1.7 Million - $2.79 Million	137,514 New	137,514 $2.68 Million
Q3 2020 Nov 16, 2020	SELL	$23.23 - $34.3 $1.53 Million - $2.26 Million	-65,839 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$12.6 - $26.55 $10.8 Million - $22.8 Million	-859,161 Reduced 92.88%	65,839 $1.61 Million
Q1 2020 May 15, 2020	BUY	$12.46 - $27.81 $1.3 Million - $2.91 Million	104,623 Added 12.75%	925,000 $13.7 Million
Q4 2019 Feb 14, 2020	BUY	$11.66 - $20.15 $9.57 Million - $16.5 Million	820,377 New	820,377 $13.3 Million
Q2 2018 Aug 14, 2018	SELL	$27.45 - $33.35 $17 Million - $20.6 Million	-618,957 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$29.15 - $37.4 $6.38 Million - $8.19 Million	218,957 Added 54.74%	618,957 $19.1 Million
Q4 2017 Feb 14, 2018	BUY	$24.55 - $36.3 $9.82 Million - $14.5 Million	400,000	400,000 $14.3 Million

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.